Skip to main content
Erschienen in: Head and Neck Pathology 1/2013

01.03.2013 | North American Society of Head and Neck Pathology Companion Meeting, March 3, 2013, Baltimore, Maryland

Adenoid Cystic Carcinoma: Clinical and Molecular Features

verfasst von: Christopher A. Moskaluk

Erschienen in: Head and Neck Pathology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

The clinical features and common molecular alterations of adenoid cystic carcinoma (ACC) are reviewed in this paper. ACC is an uncommon neoplasm that most frequently arises in salivary glands and related tissue in the head and neck region. ACC has distinct histologic features, with cribriform and tubular growth patterns of basaloid cells displaying a predominantly myoepithelial cellular phenotype. This neoplasm also has uncommon clinical features of rare regional lymph node metastasis and a prolonged but relentlessly progressive clinical course. Clinical outcome in ACC is correlated to histologic grade, which is correlated to the degree of aneuploidy and genetic alterations present in the tumor genomes. Recent studies have identified that the majority of ACC contain alterations of the MYB gene, usually resulting in a fusion gene product with the NFIB gene by a t(6;9) translocation event. The molecular consequences of this alteration are incompletely understood, as are secondary molecular alterations that contribute to the neoplastic phenotype of ACC.
Literatur
1.
Zurück zum Zitat Bonaparte JP, Hart R, Trites J, Taylor MS. Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study. J Otolaryngol Head Neck Surg. 2008;37:642–8.PubMed Bonaparte JP, Hart R, Trites J, Taylor MS. Incidence of adenoid cystic carcinoma in nova scotia: 30-year population-based epidemiologic study. J Otolaryngol Head Neck Surg. 2008;37:642–8.PubMed
2.
Zurück zum Zitat Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, Hart AA. Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors. Cancer. 1999;85:2255–64.PubMedCrossRef Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, Hart AA. Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors. Cancer. 1999;85:2255–64.PubMedCrossRef
3.
Zurück zum Zitat Spiro RH. Salivary neoplasms, overview of a 35 year experience with 2,807 patients. Head Neck Surg. 1986;8:177–84.PubMedCrossRef Spiro RH. Salivary neoplasms, overview of a 35 year experience with 2,807 patients. Head Neck Surg. 1986;8:177–84.PubMedCrossRef
4.
Zurück zum Zitat Isacsson G, Shear M. Intraoral salivary gland tumors: a retrospective study of 201 cases. J Oral Pathol. 1983;12:57–62.PubMedCrossRef Isacsson G, Shear M. Intraoral salivary gland tumors: a retrospective study of 201 cases. J Oral Pathol. 1983;12:57–62.PubMedCrossRef
5.
Zurück zum Zitat Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985;146:51–8.PubMedCrossRef Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985;146:51–8.PubMedCrossRef
6.
Zurück zum Zitat Font RL, Smith SL, Bryan RG. Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases. Arch Ophthalmol. 1998;116:613–6.PubMed Font RL, Smith SL, Bryan RG. Malignant epithelial tumors of the lacrimal gland: a clinicopathologic study of 21 cases. Arch Ophthalmol. 1998;116:613–6.PubMed
7.
Zurück zum Zitat Chen JC, Gnepp DR, Bedrossian CW. Adenoid cystic carcinoma of the salivary glands: an immunohistochemical analysis. Oral Surg, Oral Med Oral Pathol. 1988;65:316–26.CrossRef Chen JC, Gnepp DR, Bedrossian CW. Adenoid cystic carcinoma of the salivary glands: an immunohistochemical analysis. Oral Surg, Oral Med Oral Pathol. 1988;65:316–26.CrossRef
8.
Zurück zum Zitat Prasad AR, Savera AT, Gown AM, Zarbo RJ. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med. 1999;123:801–6.PubMed Prasad AR, Savera AT, Gown AM, Zarbo RJ. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med. 1999;123:801–6.PubMed
9.
Zurück zum Zitat Cheng J, Saku T, Okabe H, Furthmayr H. Basement membranes in adenoid cystic carcinoma. An immunohistochemical study. Cancer. 1992;69:2631–40.PubMedCrossRef Cheng J, Saku T, Okabe H, Furthmayr H. Basement membranes in adenoid cystic carcinoma. An immunohistochemical study. Cancer. 1992;69:2631–40.PubMedCrossRef
10.
Zurück zum Zitat Frierson HF Jr, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, Saku T, Moskaluk CA, Hampton GM. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol. 2002;161:1315–23.PubMedCrossRef Frierson HF Jr, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, Saku T, Moskaluk CA, Hampton GM. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol. 2002;161:1315–23.PubMedCrossRef
11.
Zurück zum Zitat Kimura S, Cheng J, Ida H, Hao N, Fujimori Y, Saku T. Perlecan (heparan sulfate proteoglycan) gene expression reflected in the characteristic histological architecture of salivary adenoid cystic carcinoma. Virchows Arch. 2000;437:122–8.PubMedCrossRef Kimura S, Cheng J, Ida H, Hao N, Fujimori Y, Saku T. Perlecan (heparan sulfate proteoglycan) gene expression reflected in the characteristic histological architecture of salivary adenoid cystic carcinoma. Virchows Arch. 2000;437:122–8.PubMedCrossRef
12.
Zurück zum Zitat Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984;54:1062–9.PubMedCrossRef Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984;54:1062–9.PubMedCrossRef
13.
Zurück zum Zitat Greiner TC, Robinson RA, Maves MD. Adenoid cystic carcinoma clinicopathologic study with flow cytometric analysis. Am J Clin Pathol. 1989;92:711–20.PubMed Greiner TC, Robinson RA, Maves MD. Adenoid cystic carcinoma clinicopathologic study with flow cytometric analysis. Am J Clin Pathol. 1989;92:711–20.PubMed
14.
Zurück zum Zitat Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol. 2011;34:76–81.PubMedCrossRef Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol. 2011;34:76–81.PubMedCrossRef
15.
Zurück zum Zitat Rutherford S, Yu Y, Rumpel CA, Frierson HF, Jr., Moskaluk CA: Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Cancer Lett. 2006;236:309–17. Rutherford S, Yu Y, Rumpel CA, Frierson HF, Jr., Moskaluk CA: Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Cancer Lett. 2006;236:309–17.
16.
Zurück zum Zitat Zarbo RJ. Salivary gland neoplasia: a review for the practicing pathologist. Mod Pathol. 2002;15:298–323.PubMedCrossRef Zarbo RJ. Salivary gland neoplasia: a review for the practicing pathologist. Mod Pathol. 2002;15:298–323.PubMedCrossRef
17.
Zurück zum Zitat Yamamoto Y, Saka T, Makimoto K, Takahashi H. Histological changes during progression of adenoid cystic carcinoma. J Laryngol Otol. 1992;106:1016–20.PubMedCrossRef Yamamoto Y, Saka T, Makimoto K, Takahashi H. Histological changes during progression of adenoid cystic carcinoma. J Laryngol Otol. 1992;106:1016–20.PubMedCrossRef
18.
Zurück zum Zitat Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Leon Barnes E. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol. 2007;31:1683–94.PubMedCrossRef Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Leon Barnes E. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol. 2007;31:1683–94.PubMedCrossRef
19.
Zurück zum Zitat Cheuk W, Chan JKC, Ngan RKC. Dedifferentiation in adenoid cystic carcinoma of salivary gland: an uncommon complication associated with an accelerated clinical course. Am J Surg Pathol. 1999;23:465–72.PubMedCrossRef Cheuk W, Chan JKC, Ngan RKC. Dedifferentiation in adenoid cystic carcinoma of salivary gland: an uncommon complication associated with an accelerated clinical course. Am J Surg Pathol. 1999;23:465–72.PubMedCrossRef
20.
Zurück zum Zitat Nagao T, Gaffey TA, Serizawa H, Sugano I, Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA, Lewis JE. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol. 2003;16:1265–72.PubMedCrossRef Nagao T, Gaffey TA, Serizawa H, Sugano I, Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA, Lewis JE. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol. 2003;16:1265–72.PubMedCrossRef
21.
Zurück zum Zitat Fordice J, Kershaw C, el-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck. Predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 1999;125:149–52.PubMed Fordice J, Kershaw C, el-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck. Predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg. 1999;125:149–52.PubMed
22.
Zurück zum Zitat Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004;26:154–62.PubMedCrossRef Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hinerman RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004;26:154–62.PubMedCrossRef
23.
Zurück zum Zitat Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, Phillips TL, Fu KK, Eisele DW. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006;66:152–9.PubMedCrossRef Chen AM, Bucci MK, Weinberg V, Garcia J, Quivey JM, Schechter NR, Phillips TL, Fu KK, Eisele DW. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys. 2006;66:152–9.PubMedCrossRef
24.
Zurück zum Zitat Barrett AW, Speight PM. Perineural invasion in adenoid cystic carcinoma of the salivary glands: anatomical influences on oncological management. Curr Cancer Ther Rev. 2011;7:78–82.CrossRef Barrett AW, Speight PM. Perineural invasion in adenoid cystic carcinoma of the salivary glands: anatomical influences on oncological management. Curr Cancer Ther Rev. 2011;7:78–82.CrossRef
25.
Zurück zum Zitat Conley J, Dingman DL. Adenoid cystic carcinoma in the head and neck (cylindroma). Arch Otolaryngol. 1974;100:81–90.PubMedCrossRef Conley J, Dingman DL. Adenoid cystic carcinoma in the head and neck (cylindroma). Arch Otolaryngol. 1974;100:81–90.PubMedCrossRef
26.
Zurück zum Zitat Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg. 1997;174:495–8.PubMedCrossRef Spiro RH. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg. 1997;174:495–8.PubMedCrossRef
27.
Zurück zum Zitat Nordkvist A, Mark J, Gustavsson H, Bang G, Stenman G. Nonrandom chromosome rearrangements in adenoid cystic carcinoma of the salivary glands. Genes Chromosom Cancer. 1994;10:115–21.PubMedCrossRef Nordkvist A, Mark J, Gustavsson H, Bang G, Stenman G. Nonrandom chromosome rearrangements in adenoid cystic carcinoma of the salivary glands. Genes Chromosom Cancer. 1994;10:115–21.PubMedCrossRef
28.
Zurück zum Zitat Jin Y, Mertens F, Limon J, Mandahl N, Wennerberg J, Dictor M, Heim S, Mitelman F. Characteristic karyotypic features in lacrimal and salivary gland carcinomas. Br J Cancer. 1994;70:42–7.PubMedCrossRef Jin Y, Mertens F, Limon J, Mandahl N, Wennerberg J, Dictor M, Heim S, Mitelman F. Characteristic karyotypic features in lacrimal and salivary gland carcinomas. Br J Cancer. 1994;70:42–7.PubMedCrossRef
29.
Zurück zum Zitat Jin C, Martins C, Jin Y, Wiegant J, Wennerberg J, Dictor M, Gisselsson D, Strombeck B, Fonseca I, Mitelman F, Tanke HJ, Hoglund M, Mertens F. Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH. Genes Chromosom Cancer. 2001;30:161–7.PubMedCrossRef Jin C, Martins C, Jin Y, Wiegant J, Wennerberg J, Dictor M, Gisselsson D, Strombeck B, Fonseca I, Mitelman F, Tanke HJ, Hoglund M, Mertens F. Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH. Genes Chromosom Cancer. 2001;30:161–7.PubMedCrossRef
30.
Zurück zum Zitat Higashi K, Jin Y, Johansson M, Heim S, Mandahl N, Biorklund A, Wennerberg J, Hambraeus G, Johansson L, Mitelman F. Rearrangement of 9p13 as the primary chromosomal aberration in adenoid cystic carcinoma of the respiratory tract. Genes Chromosom Cancer. 1991;3:21–3.PubMedCrossRef Higashi K, Jin Y, Johansson M, Heim S, Mandahl N, Biorklund A, Wennerberg J, Hambraeus G, Johansson L, Mitelman F. Rearrangement of 9p13 as the primary chromosomal aberration in adenoid cystic carcinoma of the respiratory tract. Genes Chromosom Cancer. 1991;3:21–3.PubMedCrossRef
31.
Zurück zum Zitat Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009;106:18740–4.PubMedCrossRef Persson M, Andren Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009;106:18740–4.PubMedCrossRef
32.
Zurück zum Zitat Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman SM, Weber RS, Caulin C, El-Naggar AK. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010;16:4722–31.PubMedCrossRef Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman SM, Weber RS, Caulin C, El-Naggar AK. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010;16:4722–31.PubMedCrossRef
33.
Zurück zum Zitat Mitani Y, Rao PH, Futreal PA, Roberts DB, Stephens PJ, Zhao YJ, Zhang L, Mitani M, Weber RS, Lippman SM, Caulin C, El-Naggar AK. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011;17:7003–14.PubMedCrossRef Mitani Y, Rao PH, Futreal PA, Roberts DB, Stephens PJ, Zhao YJ, Zhang L, Mitani M, Weber RS, Lippman SM, Caulin C, El-Naggar AK. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011;17:7003–14.PubMedCrossRef
34.
Zurück zum Zitat West RB, Kong C, Clarke N, Gilks T, Lipsick JS, Cao H, Kwok S, Montgomery KD, Varma S, Le QT. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol. 2011;35:92–9.PubMedCrossRef West RB, Kong C, Clarke N, Gilks T, Lipsick JS, Cao H, Kwok S, Montgomery KD, Varma S, Le QT. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol. 2011;35:92–9.PubMedCrossRef
35.
Zurück zum Zitat Moskaluk CA, Baras AS, Mancuso SA, Fan H, Davidson RJ, Dirks DC, Golden WL, Frierson HF Jr. Development and characterization of xenograft model systems for adenoid cystic carcinoma. Lab Invest. 2011;91:1480–90.PubMedCrossRef Moskaluk CA, Baras AS, Mancuso SA, Fan H, Davidson RJ, Dirks DC, Golden WL, Frierson HF Jr. Development and characterization of xenograft model systems for adenoid cystic carcinoma. Lab Invest. 2011;91:1480–90.PubMedCrossRef
36.
Zurück zum Zitat Brill LB, 2nd, Kanner WA, Fehr A, Andren Y, Moskaluk CA, Loning T, Stenman G, Frierson HF, Jr.: Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol. 2011;24:1169–76. Brill LB, 2nd, Kanner WA, Fehr A, Andren Y, Moskaluk CA, Loning T, Stenman G, Frierson HF, Jr.: Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol. 2011;24:1169–76.
37.
Zurück zum Zitat Bell D, Roberts D, Karpowicz M, Hanna EY, Weber RS, El-Naggar AK. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther. 2011;12:569–73.PubMedCrossRef Bell D, Roberts D, Karpowicz M, Hanna EY, Weber RS, El-Naggar AK. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther. 2011;12:569–73.PubMedCrossRef
38.
Zurück zum Zitat Bernheim A, Toujani S, Saulnier P, Robert T, Casiraghi O, Validire P, Temam S, Menard P, Dessen P, Fouret P. High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma. Lab Invest. 2008;88:464–73.PubMedCrossRef Bernheim A, Toujani S, Saulnier P, Robert T, Casiraghi O, Validire P, Temam S, Menard P, Dessen P, Fouret P. High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma. Lab Invest. 2008;88:464–73.PubMedCrossRef
39.
Zurück zum Zitat Rao PH, Roberts D, Zhao YJ, Bell D, Harris CP, Weber RS, El-Naggar AK. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res: Off J Am Assoc Cancer Res. 2008;14:5181–7.CrossRef Rao PH, Roberts D, Zhao YJ, Bell D, Harris CP, Weber RS, El-Naggar AK. Deletion of 1p32-p36 is the most frequent genetic change and poor prognostic marker in adenoid cystic carcinoma of the salivary glands. Clin Cancer Res: Off J Am Assoc Cancer Res. 2008;14:5181–7.CrossRef
40.
Zurück zum Zitat Vekony H, Ylstra B, Wilting SM, Meijer GA, van de Wiel MA, Leemans CR, van der Waal I, Bloemena E. DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clin Cancer Res. 2007;13:3133–9.PubMedCrossRef Vekony H, Ylstra B, Wilting SM, Meijer GA, van de Wiel MA, Leemans CR, van der Waal I, Bloemena E. DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma. Clin Cancer Res. 2007;13:3133–9.PubMedCrossRef
41.
Zurück zum Zitat El-Rifai W, Rutherford S, Knuutila S, Frierson HF Jr, Moskaluk CA. Novel DNA copy number losses in chromosome 12q12–q13 in adenoid cystic carcinoma. Neoplasia. 2001;3:173–8.PubMedCrossRef El-Rifai W, Rutherford S, Knuutila S, Frierson HF Jr, Moskaluk CA. Novel DNA copy number losses in chromosome 12q12–q13 in adenoid cystic carcinoma. Neoplasia. 2001;3:173–8.PubMedCrossRef
42.
Zurück zum Zitat Yu Y, Baras AS, Shirasuna K, Frierson HF Jr, Moskaluk CA. Concurrent loss of heterozygosity and copy number analysis in adenoid cystic carcinoma by SNP genotyping arrays. Lab Invest. 2007;87:430–9.PubMedCrossRef Yu Y, Baras AS, Shirasuna K, Frierson HF Jr, Moskaluk CA. Concurrent loss of heterozygosity and copy number analysis in adenoid cystic carcinoma by SNP genotyping arrays. Lab Invest. 2007;87:430–9.PubMedCrossRef
43.
Zurück zum Zitat Freier K, Flechtenmacher C, Walch A, Ohl S, Devens F, Burke B, Hassfeld S, Lichter P, Joos S, Hofele C. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet. 2005;159:89–95.PubMedCrossRef Freier K, Flechtenmacher C, Walch A, Ohl S, Devens F, Burke B, Hassfeld S, Lichter P, Joos S, Hofele C. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet. 2005;159:89–95.PubMedCrossRef
44.
Zurück zum Zitat Moskaluk CA, Frierson HF, Jr., El-Naggar AK, Futreal PA: C-kit gene mutations in adenoid cystic carcinoma are rare, Mod Pathol 2010, 23:905–906; Author reply 906–907. Moskaluk CA, Frierson HF, Jr., El-Naggar AK, Futreal PA: C-kit gene mutations in adenoid cystic carcinoma are rare, Mod Pathol 2010, 23:905–906; Author reply 906–907.
45.
Zurück zum Zitat Aubry MC, Heinrich MC, Molina J, Lewis JE, Yang P, Cassivi SD, Corless CL. Primary adenoid cystic carcinoma of the lung: absence of KIT mutations. Cancer. 2007;110:2507–10.PubMedCrossRef Aubry MC, Heinrich MC, Molina J, Lewis JE, Yang P, Cassivi SD, Corless CL. Primary adenoid cystic carcinoma of the lung: absence of KIT mutations. Cancer. 2007;110:2507–10.PubMedCrossRef
46.
Zurück zum Zitat Holst VA, Marshall CE, Moskaluk CA, Frierson HF Jr. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol. 1999;12:956–60.PubMed Holst VA, Marshall CE, Moskaluk CA, Frierson HF Jr. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol. 1999;12:956–60.PubMed
47.
Zurück zum Zitat Jeng YM, Lin CY, Hsu HC. Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett. 2000;154:107–11.PubMedCrossRef Jeng YM, Lin CY, Hsu HC. Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett. 2000;154:107–11.PubMedCrossRef
48.
Zurück zum Zitat Lin CH, Yen RF, Jeng YM, Tzen CY, Hsu C, Hong RL. Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate. Head Neck. 2005;27:1022–7.PubMedCrossRef Lin CH, Yen RF, Jeng YM, Tzen CY, Hsu C, Hong RL. Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate. Head Neck. 2005;27:1022–7.PubMedCrossRef
49.
Zurück zum Zitat Sorensen KB, Godballe C, de Stricker K, Krogdahl A. Parotid carcinoma: expression of kit protein and epidermal growth factor receptor. J Oral Pathol Med. 2006;35:286–91.PubMedCrossRef Sorensen KB, Godballe C, de Stricker K, Krogdahl A. Parotid carcinoma: expression of kit protein and epidermal growth factor receptor. J Oral Pathol Med. 2006;35:286–91.PubMedCrossRef
50.
Zurück zum Zitat Vila L, Liu H, Al-Quran SZ, Coco DP, Dong HJ, Liu C: Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland. Mod Pathol. 2009;22:1296–302. Vila L, Liu H, Al-Quran SZ, Coco DP, Dong HJ, Liu C: Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland. Mod Pathol. 2009;22:1296–302.
51.
Zurück zum Zitat Saka T, Yamamoto Y, Takahashi H. Comparative cytofluorometric DNA analysis of pleomorphic adenoma and adenoid cystic carcinoma of the salivary glands. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61:255–61.PubMedCrossRef Saka T, Yamamoto Y, Takahashi H. Comparative cytofluorometric DNA analysis of pleomorphic adenoma and adenoid cystic carcinoma of the salivary glands. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61:255–61.PubMedCrossRef
52.
Zurück zum Zitat Franzen G, Nordgard S, Boysen M, Larsen PL, Halvorsen TB, Clausen OP. DNA content in adenoid cystic carcinomas. Head Neck. 1995;17:49–55.PubMedCrossRef Franzen G, Nordgard S, Boysen M, Larsen PL, Halvorsen TB, Clausen OP. DNA content in adenoid cystic carcinomas. Head Neck. 1995;17:49–55.PubMedCrossRef
53.
Zurück zum Zitat Seethala RR, Cieply K, Barnes EL, Dacic S. Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation. Arch Pathol Lab Med. 2011;135:123–30.PubMed Seethala RR, Cieply K, Barnes EL, Dacic S. Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation. Arch Pathol Lab Med. 2011;135:123–30.PubMed
54.
Zurück zum Zitat Londono-Vallejo JA. Telomere length heterogeneity and chromosome instability. Cancer Lett. 2004;212:135–44.PubMedCrossRef Londono-Vallejo JA. Telomere length heterogeneity and chromosome instability. Cancer Lett. 2004;212:135–44.PubMedCrossRef
Metadaten
Titel
Adenoid Cystic Carcinoma: Clinical and Molecular Features
verfasst von
Christopher A. Moskaluk
Publikationsdatum
01.03.2013
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 1/2013
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-013-0426-3

Weitere Artikel der Ausgabe 1/2013

Head and Neck Pathology 1/2013 Zur Ausgabe

North American Society of Head and Neck Pathology Companion Meeting, March 3, 2013, Baltimore, Maryland

What the EWSR1-ATF1 Fusion has Taught Us About Hyalinizing Clear Cell Carcinoma

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …